XNK Therapeutics
-
XNK Therapeutics receives US orphan drug status
The status was received for NK cell-based immunotherapy in multiple myeloma XNK Therapeutics has received Orphan Drug Designation (ODD) from…
Read More »
The status was received for NK cell-based immunotherapy in multiple myeloma XNK Therapeutics has received Orphan Drug Designation (ODD) from…
Read More »